GCM
NUS icon

Gladius Capital Management’s Nu Skin NUS Stock Holding History

Gladius Capital Management’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,409
Closed -$76.7K – 193
2024
Q3 		$76.7K Buy
+10,409
New +$97.3K 0.01% 135
2024
Q1 		– Sell
-9,967
Closed -$194K – 385
2023
Q4 		$194K Buy
9,967
+1,570
+19% +$29K 0.03% 126
2023
Q3 		$178K Buy
+8,397
New +$218K 0.01% 175
2022
Q2 		– Sell
-2,278
Closed -$110K – 400
2022
Q1 		$110K Buy
2,278
+351
+18% +$17.4K 0.01% 210
2021
Q4 		$98K Buy
+1,927
New +$85.7K 0.01% 254

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Gladius Capital Management's NUS Position: Q4 2024 in Review

Gladius Capital Management sold out of Nu Skin (NUS) in Q4 2024, closing a stake of 10,409 shares — an estimated $76.7K sold.

Gladius Capital Management first reported a position in NUS in Q4 2021 and held it in 5 quarters. The position peaked at $194K in Q4 2023. 200 funds tracked by Wall St. Rank hold NUS as of Q4 2024.

  • Gladius Capital Management reported no remaining Nu Skin position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 10,409 Nu Skin shares in Q4 2024, an estimated $76.7K.
  • Gladius Capital Management first reported a position in Nu Skin in Q4 2021 and held it in 5 quarters.
  • Gladius Capital Management's Nu Skin position peaked at $194K in Q4 2023.
  • 200 funds tracked by Wall St. Rank held Nu Skin as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.